DUPILUMAB TREATMENT REDUCES HOSPITALIZATIONS IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POOLED ANALYSIS OF DATA FROM 7 RANDOMIZED, PLACEBO-CONTROLLED STUDIES

被引：0
|
作者：
Silverberg, J. [1 ]
Rubini, N. [2 ]
Pires, M. C. [3 ]
Rossi, A. [4 ]
Zhang, A. [4 ]
Chen, Z. [5 ]
Levit, N. A. [5 ]
Thomas, R. [5 ]
Shumel, B. [5 ]
Bego, G. [6 ]
机构：
[1] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[2] Fed Univ State Rio De Janeiro, Rio De Janeiro, Brazil
[3] Hosp Serv Publ Estadual Sao Paulo, Sao Paulo, Brazil
[4] Sanofi Genzyme, Cambridge, MA USA
[5] Regeneron Pharmaceut Inc, Greenwich, CT USA
[6] Sanofi, Chilly Mazarin, France
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSA13
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Dupilumab treatment reduces hospitalizations in adults with moderate-to-severe atopic dermatitis: a pooled analysis of data from seven randomized, placebo-controlled studies
    Rubini, N. P. M.
    Silverberg, J. I.
    Pires, M. C.
    Chen, Z.
    Chao, J.
    Bego-Le Bagousse, G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E116 - E117
  • [2] Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan, I
    Rubini, Norma P. M.
    Pires, Mario C.
    Rossi, Ana B.
    Zhang, Annie
    Chen, Zhen
    Levit, Noah A.
    Chao, Jingdong
    Shumel, Brad
    Bego-Le Bagousse, Gaelle
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1279 - +
  • [3] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
    Beck, Lisa A.
    Thaci, Diamant
    Hamilton, Jennifer D.
    Graham, Neil M.
    Bieber, Thomas
    Rocklin, Ross
    Ming, Jeffrey E.
    Ren, Haobo
    Kao, Richard
    Simpson, Eric
    Ardeleanu, Marius
    Weinstein, Steven P.
    Pirozzi, Gianluca
    Guttman-Yassky, Emma
    Suarez-Farinas, Mayte
    Hager, Melissa D.
    Stahl, Neil
    Yancopoulos, George D.
    Radin, Allen R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (02): : 130 - 139
  • [4] Dupilumab Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study
    Bieber, Thomas R. M.
    Thaci, Diamant
    Graham, Neil
    Pirozzi, Gianluca
    Teper, Ariel
    Ren, Haobo
    Radin, Allen
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB404 - AB404
  • [5] Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Simpson, Eric L.
    Tyring, Stephen K.
    Purcell, Lisa A.
    Shumel, Brad
    Petro, Christopher D.
    Akinlade, Bolanle
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Evans, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) : 158 - +
  • [6] The effect of dupilumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial
    Blauvelt, A.
    Simpson, E.
    Wu, R.
    Akinlade, B.
    Graham, N.
    Pirozzi, G.
    Evans, R.
    [J]. ALLERGY, 2016, 71 : 95 - 95
  • [7] Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
    Alexis, Andrew F.
    Rendon, Marta
    Silverberg, Jonathan I.
    Pariser, David M.
    Lockshin, Benjamin
    Griffiths, Christopher E. M.
    Weisman, Jamie
    Wollenberg, Andreas
    Chen, Zhen
    Davis, John D.
    Li, Meng
    Eckert, Laurent
    Gadkari, Abhijit
    Shumel, Brad
    Rossi, Ana B.
    Graham, Neil M. H.
    Ardeleanu, Marius
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (08) : 804 - 813
  • [8] Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial
    Tsianakas, A.
    Luger, T. A.
    Radin, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 406 - 414
  • [9] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [10] Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults
    Andreas Kuznik
    Gaëlle Bégo-Le-Bagousse
    Laurent Eckert
    Abhijit Gadkari
    Eric Simpson
    Christopher N. Graham
    LaStella Miles
    Vera Mastey
    Puneet Mahajan
    Sean D. Sullivan
    [J]. Dermatology and Therapy, 2017, 7 : 493 - 505
12345